Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COMMON STOCK-FO
-
Total 13F shares
-
206,840,549
-
Share change
-
+216,924
-
Total reported value
-
$16,504,468,491
-
Put/Call ratio
-
33%
-
Price per share
-
$79.76
-
Number of holders
-
598
-
Value change
-
-$99,220,163
-
Number of buys
-
317
-
Number of sells
-
283
Institutional Holders of HORIZON THERAPEUTICS PLC - COMMON STOCK-FO (HZNP) as of Q2 2022
As of 30 Jun 2022,
HORIZON THERAPEUTICS PLC - COMMON STOCK-FO (HZNP) was held by
598 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
206,840,549 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., FMR LLC, Capital International Investors, JANUS HENDERSON GROUP PLC, Nuveen Asset Management, LLC, JPMORGAN CHASE & CO, PAULSON & CO. INC., STATE STREET CORP, and Avoro Capital Advisors LLC.
This page lists
598
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.